Literature DB >> 30046891

[Lung involvement in hematologic systemic diseases].

S-S Stecher1, S Lippl2, H J Stemmler3, J Schreiber4.   

Abstract

Pulmonary diseases can occur across the entire disease spectrum of malignant hematologic systemic diseases. Although infectious processes of the lungs are common in these immunosuppressed patient collectives, noninfectious causes account for up to half of the pulmonary manifestations found in hematologic malignancies. Besides the frequent infections including opportunistic pathogens, a broad differential diagnosis including drug-induced lung injury by cytostatic substances, cytokines, and innovative immunotherapeutic agents, rarer transfusion of blood products and intrathoracic manifestations of the hematologic malignancy itself, have to be kept in mind. Finally, vascular complications can also lead to pulmonary reactions. Early and consistent diagnostics and treatment of the bronchopulmonary, intrathoracic and vascular complications within the framwework of hematologic systemic diseases can be essential for the patient's prognosis.

Entities:  

Keywords:  Complications, bronchopulmonary; Complications, vascular; Leukemia; Lymphoma; Pulmonary nodules

Mesh:

Year:  2018        PMID: 30046891     DOI: 10.1007/s00108-018-0471-9

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  59 in total

1.  Pulmonary complications in chronic lymphocytic leukemia.

Authors:  Shahid Ahmed; Anita K Siddiqui; Leonard Rossoff; Cristina P Sison; Kanti R Rai
Journal:  Cancer       Date:  2003-11-01       Impact factor: 6.860

2.  Pleural effusions in patients with acute leukemia and myelodysplastic syndrome.

Authors:  Saadia A Faiz; Lara Bashoura; Xiudong Lei; Keeran R Sampat; Tiffany C Brown; George A Eapen; Rodolfo C Morice; Alessandra Ferrajoli; Carlos A Jimenez
Journal:  Leuk Lymphoma       Date:  2012-09-10

3.  Leukemic infiltration of the lungs in the chemotherapeutic era.

Authors:  J S Ross; L Ellman
Journal:  Am J Clin Pathol       Date:  1974-02       Impact factor: 2.493

Review 4.  Primary pulmonary Hodgkin's disease.

Authors:  A I Radin
Journal:  Cancer       Date:  1990-02-01       Impact factor: 6.860

Review 5.  Thrombotic disease in the myeloproliferative neoplasms.

Authors:  Anna Falanga; Marina Marchetti
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

6.  [Lung infiltrations in Hodgkin lymphoma].

Authors:  A Ciurea-Löchel; A Ciurea; C Stey; B Pestalozzi
Journal:  Praxis (Bern 1994)       Date:  2001-08-02

Review 7.  Primary pulmonary plasmacytoma.

Authors:  G Joseph; M Pandit; L Korfhage
Journal:  Cancer       Date:  1993-02-01       Impact factor: 6.860

8.  Lung involvement in Hodgkin's disease.

Authors:  J B MacDonald
Journal:  Thorax       Date:  1977-12       Impact factor: 9.139

9.  Nonhepatosplenic extramedullary hematopoiesis: associated diseases, pathology, clinical course, and treatment.

Authors:  Cody A Koch; Chin-Yang Li; Ruben A Mesa; Ayalew Tefferi
Journal:  Mayo Clin Proc       Date:  2003-10       Impact factor: 7.616

Review 10.  Secondary pulmonary alveolar proteinosis in hematologic malignancies.

Authors:  Chakra P Chaulagain; Monika Pilichowska; Laurence Brinckerhoff; Maher Tabba; John K Erban
Journal:  Hematol Oncol Stem Cell Ther       Date:  2014-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.